Brief: Shilpa Medicare Says Unit Received Cep From Edqm For API, Nifedipine
19/11/2024 07:35
Nov 19 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SHILPA MEDICARE - UNIT RECEIVED CEP FROM EDQM FOR API,
NIFEDIPINE
* SHILPA MEDICARE - GETS CERTIFICATE OF SUITABILITY FROM
EUROPEAN
AGENCY FOR API, NIFEDIPINE
Source text: ID:nBSE349RP4
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026